Eurobio Scientific (XPAR:ALERS) Margin of Safety % (DCF Dividends Based): N/A (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALERS Eurobio Scientific XPAR:ALERS
68 GF Score
Price €20.70
GF Value €25.28
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eurobio Scientific Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Eurobio Scientific's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

XPAR:ALERS vs ABT, SYK, MDT: Margin of Safety % (DCF Dividends Based) Comparison

For the Medical Devices subindustry, Eurobio Scientific's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eurobio Scientific Margin of Safety % (DCF Dividends Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Eurobio Scientific's Margin of Safety % (DCF Dividends Based) falls into.


XPAR:ALERS
68GF Score
Eurobio Scientific XPAR:ALERS
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eurobio Scientific (XPAR:ALERS) Overvalued in 2026?

Based on GuruFocus' analysis, Eurobio Scientific stock appears to be undervalued. The current stock price of €20.70 is trading 18.1% below its estimated GF Value™ of €25.28. GuruFocus considers Eurobio Scientific to be Modestly Undervalued.

Key valuation signals for XPAR:ALERS:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €25.28 vs. price of €20.70 (18.1% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the XPAR:ALERS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurobio Scientific Business Description

Other Exchanges E8TN:Germany
Address 63-65 Boulevard Massena, Paris, FRA, 75013
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
68GF Score

Get the complete analysis for XPAR:ALERS

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.70
Price
€25.28
GF Value